Search
for
Sort by
Research 61–90 of 91
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
- Childhood‐onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report
- Intracranial hypertension as the first manifestation of systemic lupus erythematosus: A case report
- AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort
- Efficacy and Safety of Treatment with Combine Mycophenolate Mofetil and Corticosteroid for Lupus Nephritis:A Multicenter Open-label Study
- Effect of Alexandrite Laser Hair Removal on the Activity of Systemic Lupus Erythematosus
- The effect of DNMTs and MBPs on hypomethylation in systemic lupus erythematosus
- S2:04 Decoding fatigue in systemic lupus erythematosus with artificial intelligence: hematologic or inflammatory factors?
- An observational study of leflunomide in the treatment of lupus nephyritis for cyclophosphamide was invalid or could not be tolerated
- FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study
- Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity
- Ottawa, Ontario, Canada, February 13–16, 2013
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- Prevalence of thyroid dysfunction in patients with systemic lupus erythematosus: A descriptive cross sectional study
- Efficacy of Rituximab in Successful Management of Refractory Juvenile Systemic Lupus Erythematosus Complicated with Macrophage Activation Syndrome: A Case Report with Literature Overview
- Drug History and SLE Laboratory Findings Among Iraqi Patients: A Hospital‐Based Study
- AB0987 ANIFROLUMAB TREATMENT IMPROVES QUALITY OF LIFE AND DECREASES SYSTEMIC CORTICOSTEROID USE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Epidermolysis Bullosa Acquisita Occuring In A Patient With Systemic Lupus Erythematosus
- Clinical and immunological manifestations in 151 SLE patients living in Dubai
- Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan
- Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Genotype Triad for HOTAIR rs10783618, LINC-ROR rs1942347, and MALAT1 rs3200401 as Molecular Markers in Systemic Lupus Erythematous
- Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus
- Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study
- Severe hypoalbuminemia in patient with pulmonary edema and pleural effusion: a case report
- Glucocorticoid-Induced Side Effects Cause Oral Lesions in Systemic Lupus Erythematosus: A Case Report